LGC Invests in Fluidigm Corporation's Integrated Fluidic Circuit Technology

SOUTH SAN FRANCISCO, Calif. & LONDON--(BUSINESS WIRE)--Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), today announced that LGC, an international leader in laboratory services and measurement standards, has purchased a BioMark™ System for genetic analysis for use in its United Kingdom laboratories. The system, with its integrated fluidic circuit technology, adds digital PCR to LGC’s existing range of capabilities, which includes quantitative PCR, genotyping, gene expression, copy number variation and absolute quantification for sequencing.